Visit of Johnson&Johnson MedTech delegation

We were privileged to have a visit from a Johnson&Johnson MedTech delegation. It was an opportunity to discuss the origin of the Visible Patient project, with whom they have an exclusive commercial and marketing partnership. Visible Patient is led by Luc Soler, former scientific director of IRCAD. It is the perfect example of a successful technology […]
Prof. Nicolas Demartines, the new Director General of the Centre Hospitalier Universitaire Vaudois

Congratulations to Prof. Nicolas Demartines who has been appointed Director General of the Centre Hospitalier Universitaire Vaudois, ranked in the top 10 hospitals in the world. IRCAD is very proud of this since Prof. Nicolas Demartines has been teaching voluntarily in our different institutes for more than 20 years. He is considered as one of […]
Noticia Política 3D: Video: Buenos Aires: Legislatura: Reconocen como Huésped de Honor a un médico francés
El éxito de las cirugías con robots e inteligencia artificial, según el médico que hizo la primera tele-operación transatlántica
Prof. Jacques Marescaux in Latin America

What a journey it’s been for Prof. Jacques Marescaux in Latin America! He was named “Honorary Citizen of the city of Buenos Aires”, at the Governor’s Palace. The diploma was presented by Deputy Maria Sol Mendez, in charge of health at the Parliament, who praised the close collaboration between IRCAD and the Argentinean surgical community. […]
Congreso internacional sobre innovación en cirugía
Visible Patient modélise les images d’organes en 3D, pour faciliter le travail des professionnels de santé
The robots are here to stay – it’s just the beginning
Chirurgie robotique : lever les blocages au bénéfice des patients et de la collectivité
Official signing for the creation of the “IRCAD-IWC”

Check out this exclusive photo from the official signing for the creation of the “IRCAD-IWC” by Professor Christophe Mathoulin and Professor Jacques Marescaux. This collaboration has stood the test of time, and the objective remains the same – to train as many surgeons as possible throughout the world.